That FT article suggests that that the UK and US have invested more across the board albeit with a caveat
The US, UK and EU have all ordered or optioned similar numbers of vaccines on a per capita basis — more than five doses per person. But by accelerating approval processes, betting on some manufacturers and not others, and in the case of the UK and US, investing more in advance to help companies boost development and production capacity, London and Washington have made a faster start than Brussels.
In total, the UK and US have each spent about seven times more upfront, per capita, on vaccine development, procurement and production than the European bloc, according to data gathered by Airfinity, a London-based life sciences analytics company.
While the figures include different types of funding and might not be exactly comparable, the data suggest EU member states should have used more economic firepower earlier to finance upgrades of factories and vaccine raw materials suppliers, said Rasmus Bech Hansen, Airfinity’s chief executive.
Worth pointing out too that the UK supply of the Pfizer vaccine is mostly manufactured in the UK so are the EU threatening to withdraw certain ingredients from export?
@Abizzz
This is nothing to do with Brexit. The EU are threatening to withhold supply of the Pfizer vaccine or ingredients/components of it to numerous countries of which Britain may be one.
If it is correct that the EU have been put to the back of the queue because of they didn't invest as heavily to the development of the vaccine as other countries then would the countries that did invest heavily in it not have a right to be aggrieved if they are then expected to absorb the same delays as the EU?